Form 4 Tracker
Abraham Ceesay

Director; Director, Chief Executive Officer · 12 filings · Latest: Oct 6, 2026

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Rapport Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RAPP
Abraham CeesayDirector, Chief Executive OfficerOct 7, 2026
Sale
$30.661,147$35.2K452,245
RAPP
Abraham CeesayDirector, Chief Executive OfficerOct 6, 2026
Sale
$32.033,375$108.1K453,392
RAPP
Abraham N. Ceesay—Oct 6, 2026
Proposed Sale
$31.1539,470$1.2M—
RAPP
Abraham CeesayDirector, Chief Executive OfficerSep 23, 2026
Sale
$39.172,210$86.6K456,767
RAPP
Abraham CeesayDirector, Chief Executive OfficerSep 8, 2026
Sale
$45.618,210$374.5K458,977
RAPP
Abraham CeesayDirector, Chief Executive OfficerAug 25, 2026
Sale
$49.5718,921$938.0K467,187
RAPP
Abraham CeesayDirector, Chief Executive OfficerAug 11, 2026
Sale
$48.0128,958$1.4M486,108
RAPP
Abraham CeesayDirector, Chief Executive OfficerAug 10, 2026
Sale
$46.2622,541$1.0M515,066
RAPP
Abraham CeesayDirector, Chief Executive OfficerJul 27, 2026
Sale
$42.112,210$93.1K537,607
RAPP
Abraham CeesayDirector, Chief Executive OfficerJul 14, 2026
Sale
$40.008,210$328.4K539,817
RAPP
Abraham CeesayDirector, Chief Executive OfficerJun 29, 2026
Sale
$39.838,220$327.4K548,027
RAPP
Abraham N. Ceesay—Jun 29, 2026
Proposed Sale
$40.3999,480$4.0M—
PCRX
Ceesay Abraham—Jun 12, 2026
Proposed Sale
$23.279,039$210.4K—
RAPP
Abraham CeesayDirector, Chief Executive OfficerFeb 18, 2026
Sale
$29.3510,916$320.4K20,729
RAPP
Abraham CeesayDirector, Chief Executive OfficerJan 20, 2026
Sale
$26.1110,916$285.1K25,812
RAPP
THE DOROTHY CEESAY IRREVOCABLE TRUST—Dec 17, 2025
Proposed Sale
$30.7615,249$469.1K—
RAPP
ABRAHAM CEESAY—Dec 17, 2025
Proposed Sale
$30.7617,499$538.3K—
RAPP
ABRAHAM CEESAY—Sep 17, 2025
Proposed Sale
$26.1952,501$1.4M—
RAPP
THE DOROTHY CEESAY IRREV TRUST U/ADTD 03/27/2024—Sep 17, 2025
Proposed Sale
$26.1945,751$1.2M—
PCRX
Ceesay Abraham—Sep 4, 2025
Proposed Sale
$27.192,354$64.0K—